| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.004 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |